Ignite Creation Date:
2024-05-05 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00460525
Status:
COMPLETED
Last Update Posted:
2018-11-09
First Post:
2007-04-12
Brief Title:
Phase II AMA-1 Malaria Vaccine FMP21AS02A Trial in Mali
Sponsor:
US Army Medical Research and Development Command
Organization:
US Army Medical Research and Development Command
Organization Data
Organization:
US Army Medical Research and Development Command
Class:
FED
Study ID:
07-0003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
US Army Medical Research and Development Command
Lead Sponsor Class:
FED
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| University of Maryland | OTHER |
| National Institute of Allergy and Infectious Diseases NIAID | NIH |
| Walter Reed Army Institute of Research WRAIR | FED |
| GlaxoSmithKline | INDUSTRY |